Significant Ownership of Acorn Bioventures, L.P.

Signature - Title
Anders Hove - Manager of General Partner
Location
New York, NY
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Acorn Bioventures, L.P..

Notify me when Acorn Bioventures, L.P. files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Acorn Bioventures, L.P.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
OKUR OnKure Therapeutics, Inc. Common stock, par value $0.0001 per share 22.1% $7.1M 2.84M Anders Hove May 15, 2025
BCAB BioAtla, Inc. Common Stock, $0.0001 par value per share 8.3% $2.13M 4.84M Anders Hove May 15, 2025
PBYI PUMA BIOTECHNOLOGY, INC. Common Stock, $0.0001 par value per share 8% $11.9M $1.99M 3.94M +20.1% Anders Hove Dec 31, 2024
MURA Mural Oncology plc Common Stock, $0.01 par value per share 7.6% $3.37M $547K 1.29M +19.4% Anders Hove Dec 31, 2024
JSPR Jasper Therapeutics, Inc. Common Stock, $0.001 Par Value 6.4% $4.16M 1.79M Anders Hove Dec 1, 2025
YMAB Y-mAbs Therapeutics, Inc. Common stock, par value $0.0001 per share 6.2% $13.3M -$1.43M 2.8M -9.69% Anders Hove Aug 19, 2025
CADL Candel Therapeutics, Inc. Common stock, par value $0.0001 per share 5.2% $14.1M 2.58M Anders Hove Jun 25, 2025

Schedules 13D/G Reported by Acorn Bioventures, L.P.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.